Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,98 USD | +3,90% | +9,72% | -5,89% |
16/04 | XENCOR, INC. : BTIG herhaalt koopadvies voor het aandeel | ZM |
09/04 | Xencor benoemt Bart Cornelissen tot financieel directeur | MT |
Vakgebied
Aantal werknemers: 280
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Monoclonal Bispecific Antibody and Cytokine Therapeutics
100,0
%
| 165 | 100,0 % | 168 | 100,0 % | +2,28% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Global
100,0
%
| 165 | 100,0 % | 168 | 100,0 % | +2,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bassil Dahiyat
FOU | Founder | 53 | 01-08-97 |
John Desjarlais
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-07-01 |
Charles Liles
IRC | Investor Relations Contact | - | - |
Jennifer Sandoz
HRO | Human Resources Officer | - | - |
Celia Eckert
LAW | General Counsel | 52 | 10-09-19 |
Jeremy Grunstein
PRN | Corporate Officer/Principal | - | 23-05-19 |
David Szymkowski
PRN | Corporate Officer/Principal | 60 | 01-01-02 |
Raphael Clynes
PRN | Corporate Officer/Principal | - | 08-06-17 |
Nancy Valente
PRN | Corporate Officer/Principal | 66 | 08-09-22 |
Dane Leone
PRN | Corporate Officer/Principal | - | 02/01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Gorman
BRD | Director/Board Member | 66 | 14-04-17 |
Director/Board Member | 71 | 19-12-17 | |
Director/Board Member | 70 | 18-03-15 | |
Bassil Dahiyat
FOU | Founder | 53 | 01-08-97 |
Kurt Gustafson
BRD | Director/Board Member | 56 | 25-07-14 |
69 | - | ||
Barbara Klencke
BRD | Director/Board Member | 66 | 15-09-23 |
Director/Board Member | 60 | 18-12-19 | |
Nancy Valente
PRN | Corporate Officer/Principal | 66 | 08-09-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 61 647 493 | 60 478 237 ( 98,10 %) | 0 | 98,10 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
INMUNE BIO, INC. 10.46% | 1 885 533 | 10.46% | 22 155 013 $ |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,89% | 1,19 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |
- Beurs
- Aandelen
- Koers XNCR
- Onderneming Xencor, Inc.